Profiling of CD4+, CD8+, and CD4+ CD25+ CD45RO+ FoxP3+ T cells in patients with malignant glioma reveals differential expression of the immunologic transcriptome compared with T cells from healthy volunteers

被引:51
作者
Learn, Chris A.
Fecci, Peter E.
Schmittling, Robert J.
Xie, Weihua
Karikari, Isaac
Mitchell, Duane A.
Archer, Gary E.
Wei, ZhengZheng
Dressman, Holly
Sampson, John H.
机构
[1] Duke Univ, Med Ctr, Dept Surg, Div Neurosurg, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA
关键词
D O I
10.1158/1078-0432.CCR-06-1727
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Analyses of T-cell mRNA expression profiles in glioblastoma multiforme has not been previously reported but may help to define and characterize the immunosuppressed phenotype in patients with this type of cancer. Experimental Design: We did microarray studies that have shown significant and fundamental differences in the expression profiles of CD4(+) and CD8(+) T cells and immunosuppressive CD4(+)CD25(+)CD45RO(+)FoxP3(+) regulatory T cells (T-reg) from normal healthy volunteers compared with patients with newly diagnosed glioblastoma multiforme. For these investigations, we isolated total RNA from enriched CD4(+) and CD8(+) T cell or T-reg cell populations from age-matched individuals and did microarray analyses. Results: ANOVA and principal components analysis show that the various T cell compartments exhibit consistently similar mRNA expression profiles among individuals within either healthy or brain tumor groups but reflect significant differences between these groups. Compared with healthy volunteers, CD4(+) and CD8(+) T cells from patients with glioblastoma multiforme display coordinate down-regulation of genes involved in T cell receptor ligation, activation, and intracellular signaling. In contrast, T-regs from patients with glioblastoma multiforme exhibit increased levels of transcripts involved in inhibiting host immunity. Conclusion: Our findings support the notion that key differences between expression profiles in T-cell populations from patients with glioblastoma multiforme results from differential expression of the immunologic transcriptome, such that a limited number of genes are principally important in producing the dysregulated T-cell phenotype.
引用
收藏
页码:7306 / 7315
页数:10
相关论文
共 49 条
[1]  
ALBRIGHT L, 1977, CANCER, V39, P1331, DOI 10.1002/1097-0142(197703)39:3<1331::AID-CNCR2820390348>3.0.CO
[2]  
2-H
[3]   Role of tyrosine kinase inhibitors in cancer therapy [J].
Arora, A ;
Scholar, EM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03) :971-979
[4]   A selective impairment of the IL-2 system in lymphocytes of patients with glioblastomas: Increased level of soluble IL-2R and reduced protein tyrosine phosphorylation [J].
Ashkenazi, E ;
Deutsch, M ;
Tirosh, R ;
Weinreb, A ;
Tsukerman, A ;
Brodie, C .
NEUROIMMUNOMODULATION, 1997, 4 (01) :49-56
[5]  
Banerjee AG, 2003, CANCER RES, V63, P7769
[6]   Oncogenic pathway signatures in human cancers as a guide to targeted therapies [J].
Bild, AH ;
Yao, G ;
Chang, JT ;
Wang, QL ;
Potti, A ;
Chasse, D ;
Joshi, MB ;
Harpole, D ;
Lancaster, JM ;
Berchuck, A ;
Olson, JA ;
Marks, JR ;
Dressman, HK ;
West, M ;
Nevins, JR .
NATURE, 2006, 439 (7074) :353-357
[7]   Distinctions in the specificity of E2F function revealed by gene expression signatures [J].
Black, EP ;
Hallstrom, T ;
Dressman, HK ;
West, M ;
Nevins, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (44) :15948-15953
[8]  
Brooks W H, 1972, Surg Forum, V23, P430
[9]  
BROOKS WH, 1977, CLIN EXP IMMUNOL, V29, P61
[10]   DEPRESSED CELL-MEDIATED IMMUNITY IN PATIENTS WITH PRIMARY INTRACRANIAL TUMORS - CHARACTERIZATION OF A HUMORAL IMMUNOSUPPRESSIVE FACTOR [J].
BROOKS, WH ;
NETSKY, MG ;
NORMANSELL, DE ;
HORWITZ, DA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1972, 136 (06) :1631-+